Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article May 19 2025
An Antibody-Drug Conjugate Targeting VpreB1 for the Treatment of B-cell Acute Lymphoblastic Leukemia
Research Article May 19 2025
NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation
Research Article May 19 2025
PPARγ-induced Upregulation of Fatty Acid Metabolism Confers Resistance to Venetoclax and Decitabine Therapy in AML.
Research Article May 19 2025
Outcomes and factors influencing survival in patients with diffuse large B cell lymphoma: a population-based analysis
Research Article May 19 2025
Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls
Research Article May 12 2025
Real world performance of the CALGB 10403 regimen in young adults in the United States
Research Article May 11 2025
Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCT
Research Article May 11 2025
A Comparative Assessment of Molecular-Based Prognostic Models in CMML
Research Article May 11 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia
Research Article May 11 2025
Tagraxofusp, a CD123-Targeted Therapy, for Chronic Myelomonocytic Leukemia: Final Results of a Phase 1/2 Study
Research Article May 11 2025
Prognostic impact of Extranodal Disease on PET/CT in Follicular Lymphoma: Results from a Validation Study with ECOG 2408
Brief Report May 11 2025
Temporal clonal relatedness between myeloid neoplasm and nodal T follicular helper cell lymphoma: a retrospective study
Research Article April 25 2025
Activity of STAMP inhibitors in ABL2 rearranged Acute Lymphoblastic Leukemia is dependent on the Abl2 SH3 domain
Research Article April 25 2025
Checkpoint immunotherapy is associated with preferential activation of tumor-antigen specific CD4+ T cells in MDS.
Research Article April 25 2025
The oral CDK9 inhibitor voruciclib combined with venetoclax in patients with relapsed/refractory acute myeloid leukemia
Research Article April 25 2025
Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
Research Article April 16 2025
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: a Real-World Experience
Research Article April 16 2025
Outcomes at a Single Institution with MTR Induction and Consolidation in the Management of Primary CNS Lymphoma
Research Article April 16 2025
Outcomes of Myeloablative Allogeneic Hematopoietic Cell Transplantation with Omidubicel vs Haploidentical and Unrelated Donor Sources
Research Article April 16 2025
Olfactory Receptors as Tumor Suppressors in Cutaneous T-Cell Lymphoma via p38γ Pathway Modulation
Brief Report April 15 2025
Magnetic resonance spectroscopy-based detection of response to therapy targeting glutaminolysis in lymphoma
Research Article April 4 2025
A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myeloma
Brief Report April 3 2025
Reduced CD20 Expression yields Inferior Survival in Patients with B Cell Lymphoma Treated with CD20xCD3 Antibodies
Research Article April 3 2025
Ambroxol induces myeloma cell death by inhibiting autophagy
Research Article April 3 2025
Quality of life, fatigue, depression, attention deficits and pain after childhood Langerhans cell histiocytosis
Research Article March 3 2025
Phase 2 trial of daratumumab, cyclophosphamide, thalidomide and dexamethasone in newly diagnosed multiple myeloma

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals